MIT Researchers Map Distinct Mutation Pathways in Rett Syndrome to Enable Personalized Therapy

MIT neuroscientists use 3D brain organoids to prove different Rett syndrome mutations require unique treatments, paving the way for personalized medicine.

By: AXL Media

Published: Apr 15, 2026, 6:14 AM EDT

Source: Information for this report was sourced from Picower Institute at MIT

Decoding the Complexity of MECP2 Mutations

A groundbreaking study from MIT has challenged the traditional view of Rett syndrome as a uniform condition, revealing that specific genetic mutations dictate unique neural development patterns. While the disorder is generally linked to the loss of function in the MECP2 gene, researchers discovered that different mutations within that single gene cause distinct structural and electrical abnormalities. Senior author Mriganka Sur, a professor at the Picower Institute, emphasized that individual mutations are critical factors that should guide the development of personalized treatments, even in disorders caused by a single gene.

Advanced Modeling Through Cortical Organoids

To investigate these variations, the research team utilized three-dimensional human brain tissue cultures, often referred to as organoids or minibrains. These models were grown from skin or blood cells donated by patients carrying specific mutations, providing a high-fidelity platform to observe how the disorder unfolds in human tissue. Lead author Tatsuya Osaki noted that these organoids allowed for the observation of cell-to-cell interactions and structural consequences that were previously hidden in simpler models. The team focused on two specific variations: the R306C mutation, which represents a common form of the syndrome, and the rarer, more severe V247X mutation.

Disparate Structural and Network Deviations

High-resolution imaging revealed that while both mutations caused reduced neuronal activity and poor connectivity, they diverged significantly in other biological aspects. The V247X organoids were physically larger and featured altered layer thicknesses compared to controls, whereas the R306C organoids appeared structurally more typical. Furthermore, a metric of network efficiency known as small-world propensity shifted in opposite directions for each mutation, indicating that they disrupt the brain's information-processing architecture through different biological mechanisms. These findings were supported by EEG data from pediatric volunteers at Boston Children’s Hospital, suggesting the lab findings correlate with patient experiences.